Literature DB >> 24905788

PTEN.

Carolyn A Worby1, Jack E Dixon.   

Abstract

The importance of PTEN in cellular function is underscored by the frequency of its deregulation in cancer. PTEN tumor-suppressor activity depends largely on its lipid phosphatase activity, which opposes PI3K/AKT activation. As such, PTEN regulates many cellular processes, including proliferation, survival, energy metabolism, cellular architecture, and motility. More than a decade of research has expanded our knowledge about how PTEN is controlled at the transcriptional level as well as by numerous posttranscriptional modifications that regulate its enzymatic activity, protein stability, and cellular location. Although the role of PTEN in cancers has long been appreciated, it is also emerging as an important factor in other diseases, such as diabetes and autism spectrum disorders. Our understanding of PTEN function and regulation will hopefully translate into improved prognosis and treatment for patients suffering from these ailments.

Entities:  

Keywords:  cancer; phosphatase; tumor suppressor

Mesh:

Substances:

Year:  2014        PMID: 24905788     DOI: 10.1146/annurev-biochem-082411-113907

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  195 in total

1.  MEF2D deficiency in neonatal cardiomyocytes triggers cell cycle re-entry and programmed cell death in vitro.

Authors:  Nelsa L Estrella; Amanda L Clark; Cody A Desjardins; Sarah E Nocco; Francisco J Naya
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

2.  Photostable and Orthogonal Solvatochromic Fluorophores for Simultaneous In Situ Quantification of Multiple Cellular Signaling Molecules.

Authors:  Ashutosh Sharma; Jiachen Sun; Indira Singaram; Arthur Ralko; Daesung Lee; Wonhwa Cho
Journal:  ACS Chem Biol       Date:  2020-06-25       Impact factor: 5.100

3.  Nuclear PTEN deficiency causes microcephaly with decreased neuronal soma size and increased seizure susceptibility.

Authors:  Atsushi Igarashi; Kie Itoh; Tatsuya Yamada; Yoshihiro Adachi; Takashi Kato; Daisuke Murata; Hiromi Sesaki; Miho Iijima
Journal:  J Biol Chem       Date:  2018-05-07       Impact factor: 5.157

4.  Transforming growth factor-β1 and phosphatases modulate COX-2 protein expression and TAU phosphorylation in cultured immortalized podocytes.

Authors:  Maya S Abdallah; Christopher R J Kennedy; Joseph S Stephan; Pamela Abou Khalil; Mohammad Mroueh; Assaad A Eid; Wissam H Faour
Journal:  Inflamm Res       Date:  2017-10-30       Impact factor: 4.575

5.  A Saturation Mutagenesis Approach to Understanding PTEN Lipid Phosphatase Activity and Genotype-Phenotype Relationships.

Authors:  Taylor L Mighell; Sara Evans-Dutson; Brian J O'Roak
Journal:  Am J Hum Genet       Date:  2018-04-26       Impact factor: 11.025

6.  A pathogenic role for germline PTEN variants which accumulate into the nucleus.

Authors:  Janire Mingo; Isabel Rodríguez-Escudero; Sandra Luna; Teresa Fernández-Acero; Laura Amo; Amy R Jonasson; Roberto T Zori; José I López; María Molina; Víctor J Cid; Rafael Pulido
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

7.  Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model.

Authors:  Molykutty J Aryankalayil; Sunita Chopra; Adeola Makinde; Iris Eke; Joel Levin; Uma Shankavaram; Laurel MacMillan; Claire Vanpouille-Box; Sandra Demaria; C Norman Coleman
Journal:  Biomarkers       Date:  2018-06-19       Impact factor: 2.658

8.  Protein Chemical Approaches to Understanding PTEN Lipid Phosphatase Regulation.

Authors:  Daniel R Dempsey; Philip A Cole
Journal:  Methods Enzymol       Date:  2018-06-30       Impact factor: 1.600

9.  Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.

Authors:  Pierre Saintigny; Yoshitsugu Mitani; Kristen B Pytynia; Renata Ferrarotto; Dianna B Roberts; Randal S Weber; Merrill S Kies; Sankar N Maity; Sue-Hwa Lin; Adel K El-Naggar
Journal:  Cancer       Date:  2018-10-05       Impact factor: 6.860

10.  Conformational stability and catalytic activity of PTEN variants linked to cancers and autism spectrum disorders.

Authors:  Sean B Johnston; Ronald T Raines
Journal:  Biochemistry       Date:  2015-02-13       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.